Farms.com Home   News

Titan Machinery Partners with Augmenta AgTech

Titan Machinery Inc. has announced a new partnership with Augmenta AgTech. The alliance will offer U.S. farmers, particularly in the Midwest, access to the Augmenta System, a revolutionary VRA control device that fully automates a range of in-season inputs such as nitrogen, fungicides, plant growth regulators, and desiccants.

It analyzes, learns and applies in-field and in real-time to optimize inputs according to actual need. This reduces waste, soil chemical loads and input costs while maximizing yield potential. As a result, sustainability opportunities are created and profitability improved.

“In the face of ever-rising costs and environmental concerns, the Augmenta System offers a proven, no-hassle solution designed to improve efficiency and farming outcomes. That’s why we see it as a perfect fit for our customers,” said Sam Christianson, Director of Precision and Machine Control Systems for Titan Machinery.

“Augmenta is delighted to have partnered with Titan. We both realize that getting the tech out there into farmers’ hands is the only way forward for the industry. The benefits can then speak for themselves,” said Dimitri (Jim) Evangelopoulos, Augmenta Co-founder and General Manager.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.